Novocure Ltd (NVCR)

[ae kusterer]

dstock07734

Re: None

Thursday, July 27, 2023 12:54:46 PM

Post#
358
of 360
Here is the presentation from Dr. Bosch on June 3 at ASCO.

Simply take a look how many tumor associated peptides that the MHC Class 2 molecules on the surface of dendritic cells can present to the immune system. Go through these cancer vaccine companies using neo-antigen technology or mRNA technology. Will these companies be able to present huge number of peptides so that t-cells can have fully comprehensive data to identify which cell is cancer cell and which cell is normal cell? None of them can.



These cancer vaccine companies at most can only present less than 50 tumor-specific peptides to the immune system. More importantly, at best they can only activate CD8 t cells which will not trigger immune memory.